All menopause treatments containing the hormone estrogen are mandated by the US Food and Drug Administration to carry a black ...

At a recent U.S. Food and Drug Administration (F.D.A.) panel, doctors argued for the removal of the black box warning on hormone treatments used to alleviate menopause symptoms. The black box warning ...

The firm will test gedatolisib as a first-line treatment in patients with HR-positive, HER2-negative advanced breast cancer who are endocrine therapy resistant.